Table 1 Clinical and laboratory features in 145 patients with chronic myelomonocytic leukemia

Males; n (%)

98(68)

Hemoglobin g/L, median (range)

88.0(43.0–166.0)

WBC (10⁹/L), median (range)

21.88(3.01–117.57)

ANC (10⁹/L), median (range)

7.07(0.30–66.91)

AMC (10⁹/L), median (range)

3.58(1.02–57.72)

Platelets (10⁹/L), median (range)

78(4–1001)

FAB subtypes, n (%)

Myelodysplastic, MD

51(35)

Myeloproliferative, MP

94(65)

WHO subtypes, n (%)

CMML-1

84(58)

CMML-2

61(42)

Mutational status

ASXL1, n (%)

65(45)

SETBP1, n (%)

26(18)

TET2, n (%)

47(32)

SRSF2, n (%)

42(29)

^aAcute leukemic transformation; n (%)

18(14)

^aDeaths; n (%)

71(56)